Predict your next investment

Hale company logo
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
tryhale.com

See what CB Insights has to offer

Total Raised

$770K

Investors Count

2

Hale Funding, Hale Valuation & Hale Revenue

3 Fundings

Hale's latest funding round was a Unattributed - II for $0.67M on February 11, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

2/11/2020

Unattributed - II

$0.67M

Undisclosed Investors

$0.00B

((9.99x))

FY 1234

1

5/2/2019

Unattributed

$99M

$0.00B

((9.99x))

FY 1234

10

3/8/2019

Seed

$99M

$0.00B

((9.99x))

FY 1234

10

Date

2/11/2020

5/2/2019

3/8/2019

Round

Unattributed - II

Unattributed

Seed

Amount

$0.67M

$99M

$99M

Investors

Undisclosed Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

Hale Investors

2 Investors

Hale has 2 investors. Ben Franklin Technology Partners of Southeastern PA invested in Hale's Unattributed funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

5/2/2019

5/2/2019

1
Unattributed

Public-Private Partnership

Pennsylvania

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Incubator/Accelerator

United States

First funding

5/2/2019

00/00/0000

Last Funding

5/2/2019

00/00/0000

Investor

Subscribe to see more

Rounds

1
Unattributed

Subscribe to see more

Board Seats

Subscribe to see more

Type

Public-Private Partnership

Incubator/Accelerator

Location

Pennsylvania

United States

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.